Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Maria A. Gomis-Font
First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology
INTRODUCTION Antimicrobial resistance (AMR) is a major global threat (1) responsible for an estimated 1.27 million deaths in 2019 (2). This fact positions AMR as one of the most pressing challenges to global health in modern society, requiring coordinated action at all levels. This scenario in Latin America has worsened significantly, with carbapenem resistance among gram-negative bacteria increasing from 0.3% in 2002 to 21% in 2016.
Correction: Roson-Calero et al. Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii. Antibiotics 2024, 13, 1147
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections
Antimicrobial Chemotherapy Brief Report Get full access to this article View all available purchase options and get full access to this article. REFERENCES 1. López-Causapé C, Cabot G, Del Barrio-Tofiño E, Oliver A. 2018. The versatile mutational resistome of Pseudomonas aeruginosa. Front Microbiol 9:685. 2. Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S. 2019.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Maria A.
Contact Maria A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack